Le Lézard
Classified in: Health, Business
Subject: LIC

Seed & Smith Strikes Partnership with Nonprofit Cannabis Education Hotline Leaf411


DENVER, Oct. 21, 2019 /PRNewswire/ -- Seed & Smith, Colorado's leading cultivator, concentrate manufacturer and dispensary dedicated to producing high-quality cannabis, announced today its partnership with cannabis hotline Leaf411. The free hotline is staffed by cannabis-trained registered nurses providing education and directional support to the general public about the safe use of legal cannabis. Seed & Smith is a Founding Member of the nonprofit organization starting this month.

Seed & Smith's latest medical partnership aligns with its corporate mission of complete transparency, education and patient care. Leaf411's consulting nurses undergo a rigorous screening process and are trained extensively on cannabis use and the endocannabinoid system. Seed & Smith will display Leaf411 signage in retail locations, and dispensary budtenders will be able to direct all medical questions relating to cannabis use to Leaf411 nurses.

"A crucial component of advancing the legal cannabis industry is educating our customers about safe and responsible consumption," said Brooks Lustig, CEO of Seed & Smith. "There are still relatively inconsistent resources about cannabis use on the internet, and most doctors are untrained in the field of cannabis usage. Leaf411 is providing an important and accessible resource to consumers interested in engaging with the cannabis market. We're proud to partner with an outstanding advocate for patient health."

"Leaf411 was started because the founders noticed a lack of balanced, transparent and accurate educational resources related to cannabis use," said Jennifer Axcell, COO and Co-Founder of Leaf411. "For new customers, navigating the industry can feel like learning a new language, and our trained nurses are equipped to help all consumers make informed decisions about their medical and recreational use. Our team is grateful to partner with Seed & Smith and the opportunity they have provided us to reach even more cannabis users across the state."

Leaf411 is not an emergency hotline. Consumers experiencing a cannabis-related medical emergency are advised to dial 911 or go to the nearest hospital.

ABOUT SEED & SMITH
Located in Denver, Colorado, Seed & Smith is a cannabis cultivator, concentrate manufacturer and dispensary dedicated to perfecting the craft of producing high-quality cannabis while advancing the industry as a whole. With customizable professionally packaged wholesale cannabis, concentrate and flower products, Seed & Smith meticulously monitors each step of the growing process and produces the most sought-after top shelf product in all dispensaries. Seed & Smith advocates for a culture of transparency in the cannabis industry by offering tours of the grow operation, extraction lab and packaging facilities. Seed & Smith continues to stay true to its roots: creating exceptional cannabis and demonstrating their passion and process for doing so.

ABOUT LEAF411
Leaf411 is a nonprofit cannabis-trained nurse hotline aimed to help communities access balanced education about legal cannabis use while improving public perception of the cannabis industry. Consulting nurses are extensively trained in the physical and psychological side effects associated with cannabis and hemp consumption. Leaf411 is a free resource for people to call and speak directly to a medical professional that can point them in the right direction.

Media Contact:
MATTIO Communications
Mel Trecha
mel@mattio.com

 

SOURCE Seed & Smith


These press releases may also interest you

at 17:58
RubrYc Therapeutics, Inc., a pre-clinical biotherapeutics company developing epitope selective therapies to improve outcomes for cancer and serious autoimmune disease patients, today announced the appointment of Rakesh Verma, Ph.D., as the Company's...

at 17:45
The "Global Immuno-Oncology Market Demand Analysis & Opportunity Evaluation, 2019-2027" report has been added to ResearchAndMarkets.com's offering. The global immuno-oncology treatment market reached USD 53,859.48 million in 2018 and is expected to...

at 17:40
Nuvectra Corporation ("Nuvectra" or the "Company"), a neurostimulation medical device company, today announced that it has elected to file a voluntary petition for reorganization under Chapter 11 of the United States Bankruptcy Code in the U.S....

at 17:35
Personalis, Inc. , a leader in advanced genomics for cancer, today announced the launch of Personalis' Cancer Whole Genome Sequencing which further extends Personalis' portfolio of comprehensive cancer genomics services designed to maximize...

at 17:20
Seattle Genetics, Inc. today announced that it has submitted an arbitration demand to the American Arbitration Association to resolve its dispute with Daiichi Sankyo Co. Ltd. regarding the ownership of certain technology used by Daiichi Sankyo in...

at 17:00
The report predicts the global cell therapy market to grow with a healthy CAGR over the forecast period from 2019-2025. The study on cell therapy market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and...



News published on 21 october 2019 at 11:00 and distributed by: